Volltextdatei(en) vorhanden
Titel: The biological function of Cancer-testis antigen MAGE-C2/CT10 in Multiple Myeloma
Sonstige Titel: Charakterisierung der Rolle des Cancer-Testis-Antigens MAGE-C2/CT10 im Multiplen Myelom
Sprache: Englisch
Autor*in: Lajmi, Nesrine
Schlagwörter: Multiple Myeloma; Cancer-testis antigens
Erscheinungsdatum: 2013
Tag der mündlichen Prüfung: 2014-02-14
Zusammenfassung: 
Cancer-testis antigens belonging to the MAGE class I family of genes, such as MAGE-C2/CT10, are commonly expressed in Multiple Myeloma (MM). Expression of MAGE class I genes in MM is associated with aggressive disease, resistance to chemotherapy and a poor clinical outcome, suggesting that MAGE genes may confer a survival advantage on myeloma cells. MAGE-C2/CT10 is thought to be an excellent candidate for cancer immunotherapy based on its myeloma-specific expression. It was shown that MAGE-C2/CT10 enhances p53 polyubiquitination and proteasome-dependent degradation which may impair p53-dependent apoptosis. However, in spite of its frequent expression, the biological function of MAGE-C2/CT10 in malignant plasma cells has never been elucidated.
Therefore, by using the RNA interference approach, we aimed to investigate, in vitro, the impacts of MAGE-C2/CT10 silencing on the survival of tumor cells derived from MM patients.
We found that MAGE-C2/CT10 silencing inhibited the proliferation and anchorage-independent growth of myeloma cell lines, irrespective of the functional status of p53. The anti-proliferative effect of MAGE-C2/CT10 silencing was due to a decrease of cells in the S phase, a cell cycle arrest at both G0/G1 and G2/M transitions, and an increase in the subG0/G1 diploid population based on an initiation of apoptotic cell death. Importantly, MAGE-C2/C10 overexpression was able to rescue the anti-proliferative effect of MAGE-C2/CT10 depletion and protected cells from apoptotic cell death. At the molecular level, the loss of MAGE-C2/CT10 expression increased the phosphorylation of the histone variant H2A.X at Ser139, which is a sensitive indicator of DNA damage, enhanced the constitutive activation of the ATM/ATR-CHK1/CHK2 DNA damage response and led to an accumulation of the endogenous level of p53 protein. The stabilization and activation of p53, through phosphorylation at Ser20 correlated with an up-regulation of p21 (WAF1/CIP1) and GADD45Aα, which are the main mediators of p53-dependent and independent G1/S and G2/M cycle arrest, respectively, and a two-fold increase in the expression of the pro-apoptotic Bcl-2 genes BAX and BAK, being the effectors of p53-dependent and independent intrinsic apoptotic pathway in response to DNA damage.
Collectively, our findings, strongly, support an anti-apoptotic function of MAGE-C2/CT10 in MM through the regulation of key molecules involved in the regulation of DNA damage repair and p53-dependent and/or independent apoptotic pathways. The central role of MAGE-C2/CT10 in the biology of myeloma suggests that this CTA represents a promising target for myeloma-specific immunotherapies or other targeted modes of therapy for MM.
URL: https://ediss.sub.uni-hamburg.de/handle/ediss/5298
URN: urn:nbn:de:gbv:18-66187
Dokumenttyp: Dissertation
Betreuer*in: Fiedler, Walter (Prof. Dr.)
Enthalten in den Sammlungen:Elektronische Dissertationen und Habilitationen

Dateien zu dieser Ressource:
Datei Beschreibung GrößeFormat  
Dissertation.pdf19.76 MBAdobe PDFÖffnen/Anzeigen
Zur Langanzeige

Diese Publikation steht in elektronischer Form im Internet bereit und kann gelesen werden. Über den freien Zugang hinaus wurden durch die Urheberin / den Urheber keine weiteren Rechte eingeräumt. Nutzungshandlungen (wie zum Beispiel der Download, das Bearbeiten, das Weiterverbreiten) sind daher nur im Rahmen der gesetzlichen Erlaubnisse des Urheberrechtsgesetzes (UrhG) erlaubt. Dies gilt für die Publikation sowie für ihre einzelnen Bestandteile, soweit nichts Anderes ausgewiesen ist.

Info

Seitenansichten

23
Letzte Woche
Letzten Monat
geprüft am 16.04.2021

Download(s)

13
Letzte Woche
Letzten Monat
geprüft am 16.04.2021
Werkzeuge

Google ScholarTM

Prüfe